Inhaled asbestos exacerbates atherosclerosis in apolipoprotein E-deficient mice via CD4+ T cells

Environmental Health Perspectives

Volumn 116, Issue 9, 2008, Pages 1218-1225

  Fukagawa, Naomi K ^a   Li, Muyao ^a   Sabo Attwood, Tara ^b   Timblin, Cynthia R ^a   Butnor, Kelly J ^a   Gagne, Jessica ^a,d   Steele, Chad ^c   Taatjes, Douglas J ^a   Huber, Sally ^a   Mossman, Brooke T ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c University of Alabama at Birmingham   (United States)

^d Waters Inc   (United States)

Author keywords

AP 1; Atherosclerosis; CD4+ T cells; Chrysotile asbestos; Fibrosis; Inflammation; Knockout mice; Lung; MCP 1; NF B

Indexed keywords

APOLIPOPROTEIN E; ASBESTOS; CHRYSOTILE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TITANIUM DIOXIDE; TRANSCRIPTION FACTOR AP 1;

AMBIENT AIR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HISTOPATHOLOGY; INHALATION; LUNG FIBROSIS; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEINS E; ASBESTOS; ATHEROSCLEROSIS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; INHALATION EXPOSURE; MALE; MICE; MICE, KNOCKOUT;

MUS;

EID: 54149096722     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11172     Document Type: Article

References (42)

1. BéruBé KA, Quinlan TR, Moulton G, Hemenway D, O'Shaughnessy P, Vacek P, et al. 1996. Comparative proliferative and histopathologic changes in rat lungs after inhalation of chrysotile or crocidolite asbestos. Toxicol Appl Pharmacol 137:67-74.
2. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, et al. 2004. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 109:2655-2671.
3. CDC (Centers for Disease Control and Prevention). 2003. Potential exposures to airborne and settled surface dust in residential areas of lower Manhattan following the collapse of the World Trade Center - New York City, November 4- December 11, 2001. Morbid Mortal Wkly Rep 52:131-136.
4. Craighead JE. 1982. Asbestos-associated dieases: report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med 106:543-597.
5. Davenport P, Tipping PG. 2003. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 163:1117-1125.
6. Delfino RJ, Sioutas C, Malik S. 2005. Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect 113:934-946.
7. Dement JM, Harris RL Jr, Symons MJ, Shy CM. 1983. Exposures and mortality among chrysotile asbestos workers. Part II: mortality. Am J Ind Med 4:421-433.
8. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, et al. 2006. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA 295:1127-1134.
9. + T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol 165:2013-2018.
10. Feili-Hariri M, Falkner DH, Morel PA. 2005. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. J Leukoc Biol 78:656-664.
11. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, et al. 1999. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103:773-778.
12. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. 1997. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99:2752-2761.
13. Haegens A, Barrett TF, Gell J, Shukla A, MacPherson M, Vacek P, et al. 2007. Airway epithelial NF-κB activation modulates asbestos-induced inflammation and mucin production in vivo. J Immunol 178:1800-1808.
14. Hansson GK. 2001. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21:1876-1890.
15. Health Effects Institute. 1991. Asbestos in Public and Commercial Buildings: A Literature Review and Synthesis of Current Knowledge. Special Report. Boston:Health Effects Insitute.
16. Hogaboam CM, Lukacs NW, Chensue SW, Strieter RM, Kunkel SL 1998. Monocyte chemoattractant protein-1 synthesis by murine lung fibroblasts modulates CD4+ T cell activation-. J Immunol 160:4606-4614.
17. Janssen YM, Driscoll KE, Howard B, Quinlan TR, Treadwell M, Barchowsky A, et al. 1997. Asbestos causes translocation of p65 protein and increases NF-kappa B DNA binding activity in rat lung epithelial and pleural mesothelial cells. Am J Pathol 151:389-401.
18. Martin T, Cardarelli PM, Parry GCN, Felts KA, Cobb RR. 1997. Cytokine induction of monocyte chemoattractant pratein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1. Eur J Immunol 27:1091-1097.
19. McDonald JC, Liddell FD, Dufresne A, McDonald AD. 1993. The 1891-1920 birth cohort of Quebec chrysotile miners and millers: mortality 1976-88. Br J Ind Med 50:1073-1081.
20. Mossman BT, Bignon 3, Corn M, Seaton A, Gee JB. 1990. Asbestos: scientific developments and implications for public policy. Science 247:294-301.
21. Mossman BT, Gee JBL. 1989. Asbestos - related diseases. N Engl J Med 320:1721-1730.
22. Mossman BT, Hubbard A, Shukla A, Timblin CR. 2000. Role of mitogen-activated protein kinases, early response protooncogenes, and activator protein-1 in cell signaling by asbestos. Inhal Toxicol 12:307-316.
23. Nel A. 2005. Atmosphere. Air pollution-related illness: effects of particles. Science 308:804-806.
24. Nicholson WJ. 1991. Global analysis oi occupational and environmental exposure to asbestos. In: Proceedings of the Asbestos Symposium for the Countries of Central and Eastern Europe, 4-6 December 1997, Budapest, Hungary (Lehtinen S, Tossavainen A, Rantanen J, eds). People and Work. Research Reports 19. Helsinki:Finnish Institute of Occupational Health.
25. Oberdörster G, Utell MJ. 2002. Ultrafine particles in the urban air: to the respiratory tract - and beyond? [Editorial]. Environ Health Perspect 110:A440-A441.
26. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68:231-240.
27. Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. 2002. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 287:1132-1141.
28. Pope CA III, Dockery DW. 2006. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manage Assoc 56:709-742.
29. Sabo-Attwood T, Ramos-Nino M, Bond J, Butnor KJ, Heintz N, Gruber AD, et al. 2005. Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin producton in a murine model of asbestos-induced fibrogenesis. Am J Pathol 167:1243-1256.
30. Sanden A, Jarvholm B, Larsson S. 1993. The importance of lung function, non-maglinant diseases associated with asbestos, and symptoms as predictors of ischaemic heart disease in shipyard workers exposed to asbestos. Br J Ind Med 50:785-790.
31. Schreiber E, Matthias P, Müller MM, Schaffner W. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17:6419.
32. Shukla A, Lounsbury KM, Barrett TF, Gell J, Rincon M, Butnor KJ, et al. 2007. Asbestos-induced peribronchiolar cell proliferaton and cytokine production are attenuated in lungs of protein kinase C-δ knockout mice. Am J Pathol 170:140-151.
33. Sjogren B. 1997. Occupational exposure to dust: inflammation and ischaemic heart disease. Occup Environ Med 54:466-469.
34. Sjogren B. 2001. Association between pleural plaques and coronary heart disease (Letter]. Scand J Work Environ Health 27:420-421.
35. Sun Q, Wang A, Jin X, Natanzon A, Duquaine O, Brook RD, et al. 2005. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA 294:3003-3010.
36. Taatjes DJ, Wadsworth MP, Schneider DJ, Sobel BE. 2000. Improved quantitative characterization of atherosclerotic plaque composition with immunohistochemistry, confocal flourescence microscopy, and computer-assisted image analysis. Histochem Cell Biol 113:161-173.
37. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, et al. 1995. Monacyte chemotactic protem-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 95:1370-1376.
38. Upadhya S, Mooteri S, Peckham N, Pai RG. 2004. Atherogenic effect of interleukin-2 and antiatherogenic effect of interleukin-2 antibody in apo-E-deficient mice. Angiology 55:289-294.
39. Vermaelen K, Pauwels R. 2005. Pulmonary dendritic cells. Am J Respir Crit Care Med 172:530-551.
40. Wadsworth MP, Sobel BE, Schneider DJ, Taatjes DJ. 2002. Delineation of the evolution of compositional changes in atheroma. Histochem Cell Biol 118:59-68.
41. Whitman SC, Ravisankar P, Elam H, Daugherty A. 2000. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol 157:1819-1824.
42. Zhou X, Stemme S, Hansson GK. 1996. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 149:359-366.